		William 'Obi' M. Greenman President and CEO Years with Cerus : 18
Mr. Greenman was named our President and Chief Executive Officer in April 2011. He had been Cerus' Chief Business Officer since April 2010. Previously, he was senior vice president, business development and marketing. From 2006 to 2008, he held the position of president, Cerus Europe, and prior to that, he served as vice president, business development. Prior to joining Cerus in 1995 as director of business development, he worked in various marketing and business development positions in Baxter's Biotech Division from 1991 to 1995. Mr. Greenman currently is a member of the Board of Directors of Aduro Biotech. He received his B.A.S. in Economics and Biological Sciences from Stanford University.

		Laurence M. Corash, M.D. Senior Vice President, Chief Medical and Chief Scientific Officer Years with Cerus : 22
Dr. Corash, was appointed Chief Scientific Officer in 2009, and has held various medical positions within the company, including Chief Medical Officer, since 1994. Dr. Corash was a consultant to us from 1991 to 1994. He has been a Professor of Laboratory Medicine at the University of California, San Francisco since July 1985 and was Chief of the Hematology Laboratory for the Medical Center at the University of California, San Francisco from 1982 to 1997. From February 1990 to July 1994, Dr. Corash was a consultant to the FDA Advisory Panel for Hematology Devices. He currently serves on the U.S. Health and Human Services' Advisory Committee on Blood Safety and Availability.

		Howard G. Ervin Vice President, Legal Affairs Years with Cerus : 14
Mr. Ervin was appointed our Vice President, Legal Affairs in June 1999 and became our Vice President, Legal Affairs and Chief Legal Officer in 2000. As of Dec. 2012, he retired from his full time role as Chief Legal Officer and continues to provide legal counsel as Vice President, Legal Affairs in a part time capacity. Previously, Mr. Ervin was a partner of the law firm now named Cooley LLP, practicing corporate and intellectual property law.

		Andrew Gomperts Vice President, Business Development & Marketing and Chief Business Officer Years with Cerus : 1
Mr. Gomperts was appointed Chief Business Officer and Vice President, Business Development and Marketing in January 2012. Prior to joining Cerus, he served as head of corporate and business development at Sangart. Previously, Mr. Gomperts was a director in the venture operations group at Idealab, a venture capital holding company, as well as a member of the senior management team at Prometheus Laboratories, a specialty pharmaceutical company, where he was responsible for mergers and acquisitions, corporate partnering, licensing and strategic planning. Prior to Prometheus, he spent five years with McKinsey & Company. Mr. Gomperts received Bachelor of Science degrees in Chemistry and Economics from the University of California, Los Angeles, a JD from Stanford Law School and an MBA from the Wharton School.

		Kevin D. Green Vice President, Finance and Chief Financial Officer Years with Cerus : 7
Mr. Green was appointed our Chief Financial Officer in 2013. From January 2006 to February 2013, Mr. Green served in several roles for us including Senior Director of Finance, Controller and most recently, Vice President, Finance and Chief Accounting Officer. From 2000 until 2006, Mr. Green held various financial management positions with Macromedia, Inc., a software company acquired by Adobe Systems in 2005, including Director of Finance and Assistant Controller. Prior to joining Macromedia, Mr. Green was a member of PricewaterhouseCoopers LLP in the Assurance and Business Advisory Services division. Mr. Green is a certified public accountant.

		Caspar Hogeboom President, Cerus Europe Years with Cerus : 7
Mr. Hogeboom serves as President of Cerus Europe. Since joining Cerus in 2006, he has held various positions within the company including General Manager of Cerus Europe from 2011 to 2012, Managing Director of Cerus Europe from 2008 to 2011 and Managing Director, Intercept Blood Systems from 2006 to 2008. Prior to joining the Company, Mr. Hogeboom worked for Baxter Healthcare in Europe where he held several management, sales and European marketing positions from 1992 to 2006. Preceding Baxter, Mr. Hogeboom held various sales marketing positions at Maxxim Medical in the Netherlands.

		Suzanne Margerum Vice President, Manufacturing & Operations Years with Cerus : 12
Suzanne Margerum was appointed Vice President, Manufacturing in 2005. Since joining Cerus in 2001, she has held the positions of Vice President, Development; Director of Development; and Project Leader. Her previous experience includes 13 years at The Clorox Company in technical management (product development and manufacturing) for both U.S. and international business units. Ms. Margerum holds bachelors and masters degrees in chemical engineering.

		Chrystal Menard Chief Legal Officer Years with Cerus : Joined December 2012
Ms. Menard was appointed Chief Legal Officer in December 2012. Prior to joining Cerus, Ms. Menard served as senior corporate counsel at Zynga, Inc. From 2000-2011, she was a partner at Cooley LLP, where she had practiced corporate and securities law. Ms. Menard received her Juris Doctorate from the University of Chicago and her Bachelor of Science in finance and accounting from the University of Colorado, Boulder.

		Carol Moore Senior Vice President, Regulatory Affairs, Quality and Clinical Years with Cerus : 5
Ms. Moore was promoted to Senior Vice President, Regulatory Affairs, Quality, and Clinical in 2013. She has been at Cerus since 2008, previously serving as Vice President, Regulatory Affairs, Quality and Clinical. Prior to joining Cerus, she served as Vice President, Worldwide Regulatory Affairs at Bayer Corporation. Ms. Moore was with Bayer for over 30 years, during which she was involved with registration and regulatory compliance of Bayer’s biological and biotech products, health policy, and strategic planning.

		Nina Mufti Vice President, Development Years with Cerus : 5
Nina Mufti, Ph.D., was promoted to Vice President, Development at Cerus Corporation in 2012. Since 2007, she has guided the product design and development efforts for the INTERCEPT RBC System. Prior to Cerus, Dr. Mufti worked at Nektar Therapeutics on the development of drug and device combination products. Dr. Mufti completed her Ph.D. in Biochemical Engineering at Cornell University, and her Bachelors of Science, Biochemistry and Bachelors of Applied Science, Chemical Engineering at University of Ottawa.

		Lori L. Roll Vice President, Administration and Corporate Secretary Years with Cerus : 21
Ms. Roll was appointed our Vice President, Administration in 1999. From 1997 to 1999 she was our Director of Administration, and from 1992 to 1997 she served as our Controller. Prior to joining Cerus, Ms. Roll spent six years working as a certified public accountant for Ernst & Young and also served as a Controller for two private companies.

		Adonis Stassinopoulos Vice President, Global Scientific Affairs & Research Years with Cerus : 12
Dr. Stassinopoulos was appointed Vice President of Global Scientific Affairs in January 2011. Prior to rejoining Cerus he served in various positions in Chiron/Novartis V&D between 2005 to the end of 2010 including Franchise Head of Development Transfusion Medicine. From 1996 to 2005 he served Cerus in various roles including Red Cell Development Team Leader and Director within the Transfusion Medicine Research Department. Dr Stassinopoulos received his Bachelor of Science, Cum Laude, in Chemistry from Patras University in Greece, and Ph.D. in Bioinorganic Chemistry from Yale University and completed his Postdoctoral Fellowship at Harvard Medical School.

Legal |
Privacy